I agree that this site is using cookies. You can find further informations here.
X
Majethia, U.
12  results:
Search for persons X
?
1

Cost-Effectiveness Analysis of Lenvatinib as a Treatment fo..:

Tremblay, G ; Pelletier, C ; Copher, R..
Value in Health.  19 (2016)  3 - p. A151 , 2016
Link: https://doi.org/10.1016/..
 
?
2

Budget Impact and Incremental Survival Benefit of Using Len..:

Majethia, U ; Frolov, M ; Podvyaznikov, S...
Value in Health.  19 (2016)  3 - p. A143 , 2016
Link: https://doi.org/10.1016/..
 
?
3

Incremental Quality Adjusted Life Years (Qaly) Analysis in ..:

Tremblay, G ; Lloyd, A ; Majethia, U...
Value in Health.  18 (2015)  7 - p. A707 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Cost Effectiveness Analysis of Eribulin Mesylate as a Treat..:

Majethia, U. ; Tremblay, G. ; Kontoudis, I..
Value in Health.  18 (2015)  3 - p. A203 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Economic Assessment of Eribulin Against Treatment of Physic..:

Chang, CJ ; Chao, T ; Park, J...
Value in Health.  18 (2015)  7 - p. A453-A454 , 2015
Link: https://doi.org/10.1016/..
 
?
6

Cost Effectiveness Analysis of Eribulin Mesylate (Halaven®)..:

Jones, TE ; Tremblay, G ; Majethia, U...
Value in Health.  18 (2015)  7 - p. A822 , 2015
Link: https://doi.org/10.1016/..
 
?
7

Matching-Adjusted Indirect Treatment Comparison And Surviva..:

Tremblay, G ; Pelletier, C ; Forsythe, A.
Value in Health.  18 (2015)  7 - p. A435 , 2015
Link: https://doi.org/10.1016/..
 
?
8

Economic Burden of Chemotherapy Related Toxicities in Third..:

Majethia, U. ; Tremblay, G. ; He, Y.P....
Value in Health.  17 (2014)  7 - p. A628 , 2014
Link: https://doi.org/10.1016/..
 
?
9

Budget Impact and Incremental Survival Benefit of Eribulin ..:

Majethia, U. ; Tremblay, G. ; Borges, L....
Value in Health.  17 (2014)  7 - p. A623 , 2014
Link: https://doi.org/10.1016/..
 
?
10

Off-label prescribing and polytherapy of atypical antipsych..:

Shanbhag, P. ; Majethia, U. ; Nayak, R.
Value in Health.  17 (2014)  3 - p. A223 , 2014
Link: https://doi.org/10.1016/..
 
?
11

PND40 Assessment of Dementia Risk Among Caregivers of Alzhe..:

Majethia, U. ; Nayak, R.
Value in Health.  15 (2012)  4 - p. A148 , 2012
Link: https://doi.org/10.1016/..
 
?
12

Economic evaluation of eribulin as second-line treatment fo..:

Tremblay G ; Majethia U ; Breeze JL..
https://www.dovepress.com/economic-evaluation-of-eribulin-as-second-line-treatment-for-metastati-peer-reviewed-article-CEOR.  , 2016
Link: https://doaj.org/article..
 
1-12